Net Cash Provided by (Used in) Operating Activities |
197 |
USD |
|
Q3 2024 |
Q3 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
197 |
USD |
|
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.61K |
USD |
-18.4% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
47.7M |
USD |
+18.3% |
Q3 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Gross |
47.7M |
USD |
+18.3% |
Q3 2024 |
Q3 2024 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
3.47M |
USD |
-24.9% |
Q3 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
Q3 2024 |
Additional Paid in Capital |
177M |
USD |
0% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2024 |
Q1 2024 |